Argenx to present at goldman sachs 45th annual global healthcare conference

June 4, 2024 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the goldman sachs 45th annual global healthcare conference on tuesday, june 11, 2024 at 2:40 pm et in miami, fl.
ARGX Ratings Summary
ARGX Quant Ranking